EOG RESOURCES INC·4

May 4, 12:39 PM ET

Donaldson Michael P 4

4 · EOG RESOURCES INC · Filed May 4, 2026

Research Summary

AI-generated summary of this filing

Updated

EOG Resources EVP Michael P. Donaldson Receives 155 Shares

What Happened
Michael P. Donaldson, EVP and Chief Legal Officer of EOG Resources, received an award of 155.26 shares on 2026-04-30 at a reported value of $140.57 per share (total ≈ $21,825). On the same date he had a small disposition of 0.398 shares at $140.57 (≈ $56) to the issuer, which is commonly associated with withholding related to the award. This was an equity award/grant (acquisition), not an open-market purchase.

Key Details

  • Transaction date: 2026-04-30; Form 4 filed 2026-05-04 (filed within required reporting window).
  • Award (A): 155.26 shares at $140.57 each — total value ≈ $21,825.
  • Disposition to issuer (D): 0.398 shares at $140.57 — value ≈ $56 (likely withholding).
  • Shares owned after the transaction: not specified in the information provided.
  • Transaction codes: A = Award/Grant (acquisition); D = Disposition to issuer (often for tax withholding).

Context
This filing documents an equity award to an executive rather than a market purchase or sale. Such grants are standard compensation for executives and do not, by themselves, indicate trading sentiment. The small share disposition to the issuer typically reflects tax withholding related to the award.

Insider Transaction Report

Form 4
Period: 2026-04-30
Donaldson Michael P
EVP & Chief Legal Officer
Transactions
  • Award

    Common Stock

    2026-04-30$140.57/sh+155.26$21,825107,513.661 total
  • Disposition to Issuer

    Common Stock

    2026-04-30$140.57/sh0.398$56107,513.263 total
Holdings
  • Common Stock

    (indirect: By Trust)
    10,000
  • Common Stock

    (indirect: By Trust)
    10,000
  • Common Stock

    (indirect: By Trust)
    10,000
Signature
Michael E. Montifar, attorney-in-fact for Michael P. Donaldson|2026-05-04

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT